NOVA (ENGOT-OV16): Niraparib Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer Last updated on Jun 8, 2026 Previous ICON7: Bevacizumab in Front-Line Ovarian Cancer Next VELIA: Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
